Company page
Clene Inc.
Clene Inc. is a public company traded under the ticker CLNN in the American market, with a market capitalization of approximately $75.6 million. The company focuses on developing innovative therapies for neurodegenerative diseases. Clene aims to improve patient outcomes through its unique approach to treatment.
- Ticker
- CLNN:NASDAQ
- Asset type
- Stock
- Market cap
- $45.9M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD